Most people who take a GLP-1 will have a side effect at some point. The medication works partly by slowing how fast food leaves the stomach, which is what produces the satiety effect that makes weight loss possible. It's also what produces most of the GI symptoms patients describe. The good news: the side effects are usually manageable, mostly time-limited, and almost always proportional to dose changes rather than to absolute dose.
This guide walks through what's actually happening physiologically, what's been shown to help, and the small number of situations that warrant a call to your provider rather than a wait-and-see approach.
What the data actually shows
In the pivotal SURPASS and SURMOUNT trials, the most commonly reported gastrointestinal adverse events were nausea (up to 32% of participants), diarrhea (up to 23%), vomiting (up to 12%), and constipation (up to 11%). A 2025 Reddit-corpus analysis of real-world GLP-1 users (May 2019 to June 2025, nine subreddits, GPT-4o-classified) reported nausea in 36.9%, fatigue in 16.7%, vomiting in 16.3%, constipation in 15.3%, and diarrhea in 12.6%. Real-world rates are slightly higher than trial rates, which is the pattern across most chronic medications.
The shape of the curve matters more than the headline number. Side effects cluster around dose-escalation events. Most patients tolerate a steady dose well; the bumpy weeks are the ones where the dose is being titrated up.
Nausea
The most common complaint. The mechanism is straightforward: GLP-1 receptors are present in the area postrema of the brainstem (a region involved in nausea signaling) and the medication delays gastric emptying, so food sits in the stomach longer than the body is used to. Both effects produce the queasy, full feeling that patients describe.
What helps
- Smaller, more frequent meals. The single most consistently helpful intervention. Three large meals a day overload a stomach that's emptying slowly. Five or six small meals distribute the volume.
- Lower the fat content. High-fat meals empty more slowly than low-fat meals at baseline; on a GLP-1, the effect compounds. Patients consistently report fewer symptoms on lower-fat, higher-protein meals.
- Eat slowly and stop when full. Satiety signals arrive faster on a GLP-1. The first sign of fullness is usually the right place to stop.
- Stay hydrated. Dehydration worsens nausea. Aim for steady fluid intake throughout the day, not large boluses at meals.
- Vitamin B6. 10-25 mg up to three times daily has been shown to reduce nausea in pregnancy and is commonly used by GLP-1 patients. The evidence base is strongest in pregnancy nausea, but the mechanism is plausibly the same.
- Ginger. 250-1000 mg of ginger root extract has antiemetic effects supported by chemotherapy-induced nausea trials. Ginger tea or capsules both work.
- Ondansetron (Zofran). If nausea is interfering with daily life, ask your provider about a prescription. It's effective and well-tolerated for occasional use.
What to avoid
- Large boluses of fat or alcohol. Both worsen gastric stasis on a GLP-1. A heavy meal is the most common trigger of a bad nausea episode.
- Lying down right after eating. Stay upright for at least 60 minutes after meals.
- Pushing through a dose increase when you're already symptomatic. If you're not tolerating the current dose, hold rather than escalate.
Fatigue
Less talked about than nausea, but extremely common. The 2025 Reddit analysis flagged fatigue as the second most-reported symptom (16.7%), and a notable finding because it's not always captured well in clinical trial labeling. The cause is multi-factorial: rapid weight loss draws on glycogen stores, lower caloric intake means lower thermogenic substrate, and dehydration is common when appetite is suppressed.
What helps
- Prioritize protein. If you're eating less overall, protein should be the macronutrient that doesn't get cut. 1.2 g per kg of body weight per day is a reasonable floor; many clinicians recommend 1.6 g per kg or higher.
- Don't under-eat. GLP-1s suppress appetite; that doesn't mean you should ignore caloric needs entirely. Aim for moderate, sustained deficits rather than aggressive restriction.
- Electrolytes. Sodium, potassium, and magnesium intake often drops along with food intake. Salt your food, eat potassium-rich foods like avocado and potato, and consider a magnesium supplement at night.
- Move. Counterintuitive, but light to moderate exercise consistently helps fatigue rather than worsening it.
Constipation
The same slowed gastric emptying that produces satiety also slows transit through the colon. Combined with lower fiber intake (because total food intake is lower) and frequent under-hydration, constipation is predictable.
What helps
- Fiber. 25-35 g per day from food where possible; a soluble fiber supplement (psyllium, methylcellulose) covers the gap if intake is low. Start gradually to avoid bloating.
- Fluids. Fiber without fluid worsens constipation. Drink water throughout the day.
- Magnesium citrate. 200-400 mg at night is gentle, effective, and well-tolerated for most patients.
- Walk after meals. Even ten minutes of light walking helps motility.
- Osmotic laxatives. Polyethylene glycol (Miralax) is non-stimulant and safe for daily use if needed.
Diarrhea
Less common than constipation on semaglutide; somewhat more common on tirzepatide. A 2024 meta-analysis reported diarrhea risk ratios of 1.81-2.18 for tirzepatide and 1.66-1.80 for semaglutide versus placebo. When diarrhea happens, it's usually transient and tied to dose changes.
What helps
- Hold the next dose escalation. Stay at the tolerated dose until symptoms resolve.
- Low-fiber, bland foods. The BRAT pattern (banana, rice, applesauce, toast) is gentle and reliable for short-term recovery.
- Loperamide (Imodium). Reasonable for short-term symptom control. If you're using it more than two days in a row, contact your provider.
- Replace electrolytes. Diarrhea depletes sodium and potassium quickly. Oral rehydration solutions or a sports drink work.
The sulfur burps
One of the most-discussed but least-studied side effects. Patients report burps with a distinct rotten-egg smell, usually starting within hours of an injection and lasting up to a day or two. The mechanism is not fully established but is thought to involve sulfur-reducing bacteria in a slowed-emptying stomach producing hydrogen sulfide. The smell is striking and the symptom is rarely dangerous.
What helps
- Reduce sulfur-rich foods around injection day. Cruciferous vegetables (broccoli, cauliflower, cabbage), eggs, red meat, and garlic are common culprits. Easing back temporarily can help.
- Bismuth subsalicylate (Pepto-Bismol). Binds hydrogen sulfide and reduces the odor. Effective for many patients.
- Inject at a time of day when post-injection nausea is manageable. Some patients prefer evening injections so the worst of the symptoms happen during sleep.
Heartburn and reflux
Slowed gastric emptying can worsen gastroesophageal reflux, particularly in patients who already have GERD. The increase is usually mild and responds to standard interventions.
What helps
- Avoid large meals before bed. Stop eating at least three hours before lying down.
- Elevate the head of the bed. A wedge pillow or 4-6 inches under the bed legs makes a difference.
- Skip late-night fat, alcohol, and coffee. All three relax the lower esophageal sphincter.
- H2 blockers or PPIs. Famotidine 20 mg or 40 mg at night, or a short course of omeprazole, controls symptoms when lifestyle changes aren't enough.
When to call your provider
Most side effects are nuisances that resolve with the strategies above. A small number are signals that something more serious is happening and they should not be ignored.
- Severe abdominal pain, especially mid-abdomen radiating to the back, that doesn't improve. This is the classic presentation of pancreatitis, which is a known rare risk of GLP-1 therapy and requires urgent evaluation.
- Persistent vomiting that prevents you from keeping fluids down for more than 24 hours. Dehydration on a GLP-1 can become serious quickly.
- Right upper quadrant pain, particularly after a fatty meal, with or without fever or jaundice. Could indicate gallbladder disease, which is more common during rapid weight loss.
- Vision changes, particularly in patients with diabetes. Rapid glycemic improvement can transiently worsen diabetic retinopathy.
- Signs of dehydration: dizziness on standing, dark or absent urine, dry mouth that doesn't resolve with fluids.
- Mood changes that feel out of proportion to circumstance. Most patients describe stable or improved mood on GLP-1s, but a small subset experience low mood or anhedonia that's worth raising with a provider.
The titration question
The single most controllable variable in side-effect tolerance is how aggressively the dose is escalated. Standard manufacturer titration schedules step up monthly, but real-world tolerance varies. There is no penalty for staying at a lower dose longer if a patient is doing well clinically. Patients can lose meaningful weight at sub-maximal doses; the goal is the lowest effective dose, not the highest tolerated dose.
If a dose change produces side effects that don't resolve in 1-2 weeks, the right next step is usually to step back down to the previously tolerated dose for another month before trying again. This is a conversation to have with your provider; most clinicians are comfortable with flexible titration when patients communicate clearly.
Tirzepatide vs semaglutide tolerability
Recent comparative data suggests tirzepatide may produce slightly fewer GI side effects than semaglutide at comparable weight-loss outcomes. A 2025 preclinical study from Penn Nursing in Science Advances found that tirzepatide produced fewer nausea-like behaviors than semaglutide at matched doses, attributed to the dual GIP/GLP-1 agonism (GIP signaling appears to buffer some of the nausea-producing effects of GLP-1 alone). A Frontiers in Pharmacology 2025 network meta-analysis confirmed somewhat higher diarrhea rates for tirzepatide but slightly lower nausea and vomiting compared to semaglutide.
The practical implication: patients who can't tolerate semaglutide are sometimes able to tolerate tirzepatide, and vice versa. Switching is reasonable when symptoms are dose-limiting.
The Bottom Line
GLP-1 side effects are common, almost always manageable, and almost always front-loaded in the first few months. The interventions that work are not exotic: smaller meals, lower fat, slower titration, hydration, fiber, electrolytes. The medications work; the side effects are the cost of admission. Done thoughtfully, the cost is small and time-limited.
Talk to your provider about titration flexibility, switching between semaglutide and tirzepatide if one isn't tolerable, and the small number of red-flag symptoms that warrant urgent evaluation. The rest can be managed at home.